Insulinespuit 0,5ml met fijne naaldAlso known as: Insulin syringe 0.5ml with fine needle, U100 insulin syringe 0.5 ml 0.30 x 8 mm needle

Mechanism of Action

This product is not a peptide but a sterile insulin syringe designed for precise subcutaneous delivery of liquid compounds such as peptides. It facilitates the controlled administration of substances directly into subcutaneous tissue, ensuring accurate dosing and minimizing tissue damage.

Reported Research Benefits

• Used primarily for subcutaneous injection of peptides (e.g., BPC-157, TB-500, Ipamorelin) and other small volume liquid compounds in laboratory or research settings.

Dosing Protocol & Reconstitution

Research Notes

Provides consistent, sterile, and accurate dosing for peptide administration which is critical for reproducible research outcomes. Needle size (0.30 x 8 mm) is optimized for minimal pain and tissue trauma in peptide subcutaneous injection.

Research Summary

Insulinespuit 0,5ml met fijne naald is a sterile insulin syringe primarily used for the subcutaneous administration of insulin and other injectable compounds. While it is not a therapeutic peptide itself, its design facilitates precise dosing and minimizes tissue trauma, which is critical in both clinical and research settings involving peptide delivery. Studies on insulin delivery emphasize that the use of appropriately sized syringes and fine needles improves patient compliance and reduces injection site complications. The evidence supporting these benefits is drawn mainly from clinical practice guidelines and observational studies, rather than randomized controlled trials specific to the syringe device itself. Limitations include a lack of direct clinical trial data on the syringe independent of the injected compound.

Side Effects & Safety

As a medical device rather than a pharmacologic agent, the insulin syringe itself does not have intrinsic side effects but carries safety considerations related to injection technique and sterility. Improper use can lead to injection site pain, bruising, infection, or lipodystrophy due to repeated injections in the same site. Needle reuse and poor hygiene increase the risk of local infection and cross-contamination. There are no known drug interactions related to the syringe, but care must be taken when handling anticoagulants or other injectable medications. Additionally, while the syringe is not subject to WADA regulations, substances administered using it may be regulated. Proper disposal of needles is essential to avoid needlestick injuries.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=Insulin+syringe+0.5ml+with+fine+needle